PL352024A1 - Medicinal substance utilization for preventing nitrate tolerance - Google Patents

Medicinal substance utilization for preventing nitrate tolerance

Info

Publication number
PL352024A1
PL352024A1 PL00352024A PL35202400A PL352024A1 PL 352024 A1 PL352024 A1 PL 352024A1 PL 00352024 A PL00352024 A PL 00352024A PL 35202400 A PL35202400 A PL 35202400A PL 352024 A1 PL352024 A1 PL 352024A1
Authority
PL
Poland
Prior art keywords
medicinal substance
nitrate tolerance
substance utilization
preventing
preventing nitrate
Prior art date
Application number
PL00352024A
Other languages
English (en)
Inventor
Michael Stoeter
Gerd Koenig
Eberhard Bassenge
Original Assignee
Alpharma Isis Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma Isis Gmbh & Co Kg filed Critical Alpharma Isis Gmbh & Co Kg
Publication of PL352024A1 publication Critical patent/PL352024A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL00352024A 1999-05-05 2000-05-05 Medicinal substance utilization for preventing nitrate tolerance PL352024A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19920775A DE19920775A1 (de) 1999-05-05 1999-05-05 Arzneistoffverwendung zur Vermeidung von Nitrattoleranz

Publications (1)

Publication Number Publication Date
PL352024A1 true PL352024A1 (en) 2003-07-14

Family

ID=7907118

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00352024A PL352024A1 (en) 1999-05-05 2000-05-05 Medicinal substance utilization for preventing nitrate tolerance

Country Status (6)

Country Link
EP (1) EP1173214A2 (de)
AU (1) AU5802000A (de)
BG (1) BG105955A (de)
DE (1) DE19920775A1 (de)
PL (1) PL352024A1 (de)
WO (1) WO2000067731A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537992B2 (en) 2001-01-05 2003-03-25 John D. Parker Regulation of organic nitrate tolerance
GB0909243D0 (en) * 2009-05-29 2009-07-15 Univ Dundee Angina treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839826A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikaemie und gicht

Also Published As

Publication number Publication date
WO2000067731A2 (de) 2000-11-16
AU5802000A (en) 2000-11-21
BG105955A (bg) 2002-06-28
EP1173214A2 (de) 2002-01-23
DE19920775A1 (de) 2000-11-16
WO2000067731A3 (de) 2001-01-25

Similar Documents

Publication Publication Date Title
IL149224A0 (en) Hydrogen-driven drug dosage form
EG23858A (en) Drug combination
IL145632A0 (en) Pharmaceutical compounds
GB9930079D0 (en) Medicaments
GB9930071D0 (en) Medicaments
GB9916434D0 (en) Pharmaceutical compounds
IL148543A0 (en) Pharmaceutical carrier formulation
GB9914255D0 (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
GB9915231D0 (en) Pharmaceutical complex
PL352024A1 (en) Medicinal substance utilization for preventing nitrate tolerance
GB9930083D0 (en) Medicaments
GB9924990D0 (en) Medicaments
GB2373499B (en) Pharmaceutical compounds
GB9929040D0 (en) Medicaments
GB9930082D0 (en) Medicaments
GB9904935D0 (en) Medicaments
GB9929039D0 (en) Medicaments
GB9930106D0 (en) Medicaments
GB9902251D0 (en) Medicaments
GB9910076D0 (en) Medicaments
GB9901236D0 (en) Medicaments
GB9923675D0 (en) Medicaments
GB9910916D0 (en) Medicaments
GB9915471D0 (en) Medicaments

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)